NUCLEAR-DNA CONTENT AS A PROGNOSTIC FACTOR IN T1-2N0 BREAST-CANCER

被引:44
作者
TOIKKANEN, S [1 ]
JOENSUU, H [1 ]
KLEMI, P [1 ]
机构
[1] UNIV TURKU, CENT HOSP, DEPT RADIOTHERAPY, SF-20520 TURKU 52, FINLAND
关键词
Breast cancer; Flow cytometry; Long-term survival; Prognostic factors;
D O I
10.1093/ajcp/93.4.471
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
One hundred fifteen patients with postsurgical stage T1-2N0 breast cancer with the minimum follow-up of 22 years and from a defined population were studied to find reliable prognostic factors predicting long-term survival rate. The 30-year survival rate corrected for intercurrent deaths was 75%, and no deaths of breast cancer occurred after the nineteenth year of follow-up. The 30-year crude survival rate was only 28%, indicating that the great majority of these patients ultimately die of other causes than breast cancer. The nuclear DNA content could be determined by flow cytometry in 95 of the 115 cases, and 52 (55%) of them were nondiploid. DNA ploidy (diploid vs. nondiploid, P = 0.11) did not have a significant influence on long-term survival rate, but cancers with the DNA index less than 1.2 had more favorable prognosis in a univariate analysis than those with the DNA index more than 1.2 (P = 0.02). The most important independent prognostic factor in Cox's multivariate analysis was the presence of lymphatic vessel invasion of cancer cells (P < 0.001). Several other factors, including histologic grade and type, extent of necrosis, type of tumor margin, age at diagnosis, and primary tumor size could be shown to be of prognostic value in univariate and/or multivariate analyses.
引用
收藏
页码:471 / 479
页数:9
相关论文
共 50 条
  • [21] NUCLEAR PLEOMORPHISM, A STRONG PROGNOSTIC FACTOR IN AXILLARY NODE-NEGATIVE SMALL INVASIVE BREAST-CANCER
    STIERER, M
    ROSEN, H
    WEBER, R
    BREAST CANCER RESEARCH AND TREATMENT, 1992, 20 (02) : 109 - 116
  • [22] Predicting aggressive outcome in T1N0M0 breast cancer
    P Kronqvist
    T Kuopio
    M Nykänen
    H Helenius
    J Anttinen
    P Klemi
    British Journal of Cancer, 2004, 91 : 277 - 281
  • [23] Predicting aggressive outcome in T1N0M0 breast cancer
    Kronqvist, P
    Kuopio, T
    Nykänen, M
    Helenius, H
    Anttinen, J
    Klemi, P
    BRITISH JOURNAL OF CANCER, 2004, 91 (02) : 277 - 281
  • [24] Protein tyrosine kinase activity in 350 T1/T2, N0/N1 breast cancer. Preliminary results
    Bolla, M
    RostaingPuissant, B
    Bottari, SP
    Chedin, M
    MarronCharriere, J
    Colonna, M
    Berland, E
    Chambaz, E
    BREAST CANCER RESEARCH AND TREATMENT, 1996, 39 (03) : 327 - 334
  • [25] LACK OF PROGNOSTIC VALUE OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN A SERIES OF 229 T1/T2, N0/N1 BREAST CANCERS, WITH WELL-DEFINED PROGNOSTIC PARAMETERS
    BOLLA, M
    CHEDIN, M
    COLONNA, M
    MARRONCHARRIERE, J
    ROSTAINGPUISSANT, B
    PASQUIER, D
    PANH, MH
    WINCKEL, P
    CHAMBAZ, EM
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 29 (03) : 265 - 270
  • [26] Gene expression profiles in clinically T1-2N0 ER+HER2− breast cancer patients treated with breast-conserving therapy: their added value in case sentinel lymph node biopsy is not performed
    L. M. van Roozendaal
    M. L. G. Vane
    E. Colier
    L. J. A. Strobbe
    M. de Boer
    G. Sonke
    M. C. Van Maaren
    M. L. Smidt
    Breast Cancer Research and Treatment, 2024, 203 : 103 - 110
  • [27] PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IMMUNOLABELING AS A PROGNOSTIC FACTOR IN AXILLARY LYMPH-NODE NEGATIVE BREAST-CANCER
    AALTOMAA, S
    LIPPONEN, P
    SYRJANEN, K
    ANTICANCER RESEARCH, 1993, 13 (02) : 533 - 538
  • [28] Gene expression profiles in clinically T1-2N0 ER+HER2-breast cancer patients treated with breast-conserving therapy: their added value in case sentinel lymph node biopsy is not performed
    van Roozendaal, L. M.
    Vane, M. L. G.
    Colier, E.
    Strobbe, L. J. A.
    de Boer, M.
    Sonke, G.
    Van Maaren, M. C.
    Smidt, M. L.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (01) : 103 - 110
  • [29] PS2 PROTEIN AS PROGNOSTIC FACTOR IN 1065 CASES OF HUMAN BREAST-CANCER - A MULTICENTRIC STUDY
    BESSE, G
    KWIATKOWSKI, F
    GAILLARD, G
    DAVER, A
    DALIFARD, I
    BASUYAU, JP
    BRUNELLE, P
    WAFFLART, J
    ANGIBEAU, RM
    AUVRAY, E
    GOUSSARD, J
    BULLETIN DU CANCER, 1994, 81 (04) : 289 - 296
  • [30] Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study 1. DNA synthesis enzyme activities
    Spyratos, F
    Romain, S
    Rostaing-Puissant, B
    Daver, A
    Colonna, M
    Descotes, F
    Martin, PM
    Bougnoux, P
    Roth, H
    Bolla, M
    BULLETIN DU CANCER, 1999, 86 (7-8) : 678 - 684